Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G for CONTINEUM THERAPEUTICS, INC. Class A Common Stock (CTNM).
- Disclosed ownership: 7.9%.
- Date of event: 31 Dec 2025.
JANUS HENDERSON GROUP PLC - 31 Dec 2025 SCHEDULE 13G Report for CONTINEUM THERAPEUTICS, INC. Class A Common Stock (CTNM)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Symbol
- CTNM
- Shares outstanding
- 30,999,734 shares
- Disclosed Ownership
- 2,448,979 shares
- Ownership
- 7.9%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 12:57:28 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 7.9% ownership in CONTINEUM THERAPEUTICS, INC. Class A Common Stock (CTNM) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 12:57.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.9% | 2,448,979 | 0 | 2,448,979 | Kristin Mariani | Head of North America Compliance |